Lutnick wants U.S. to profit from university patents, which could reshape VC math
Add Axios as your preferred source to
see more of our stories on Google.
Commerce Secretary Howard Lutnick wants the U.S. government to get a cut of university patent revenue, or even commercial revenue derived from those patents, he tells Axios' Mike Allen on tomorrow's premier episode of "The Axios Show."
Why it matters: This could disrupt the startup ecosystem, particularly in biotech.
What Lutnick said: "I think universities, who are getting all this money. The scientists get the patents, the universities get the patents and the funder of $50 billion, the U.S. government, you know what we get? Zero."
- "The U.S. government gives someone $50 million and let's say they invent a drug, a patent, the drug, and it's worth $50 million," he continued. "Why did they make the 50 and we lost 50? We should get our money back and participate."
- "Then what'll happen is our Social Security system will be paid for and we won't be a broke country running $2 trillion deficits."
- Lutnick adds that he sent Harvard a letter to this effect last week, but the school didn't respond to Axios' request for comment. He also plans to send letters to "the California system" this week.
What to know: Lots of VC-backed startups have their roots in government-funded academic research, and sometimes pay universities to license patents.
- But the amounts tend to be relatively small (i.e., not nearly enough to solve Social Security's solvency issues).
- For example, Harvard University received just $54 million in commercialization revenue for fiscal 2024, down from $107 million during fiscal 2024. And that's for all of its labs, not just those receiving grants from the NIH or other federal sources.
- Moreover, Harvard and other schools tend to reinvest that money into research.
Zoom in: The Commerce Department isn't clarifying if Lutnick meant that the U.S. government should receive actual equity stakes in startups, or other companies commercializing such patents.
- If so, it would change the math for venture capitalists whose money is required to move those ideas from the lab to the market. A possible chilling effect.
The bottom line: Every White House wants a return on its investments. Usually, however, it's in the form of improving national health or national security — taxpayer dollars benefiting taxpayers.
- For Lutnick and others in Trump 2.0, it's more about the actual dollars.
